Hale Jaeger

Publications (1)

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.

The lancet. HIV

Avec: Hans Jaeger , Edgar T Overton , Gary Richmond , Giuliano Rizzardini , Jaime Federico Andrade-Villanueva , Rosie Mngqibisa , Antonio Ocampo Hermida , Anders Thalme , Elena Belonosova , Faïza Ajana , Paul D Benn , Yuanyuan Wang , Krischan J Hudson , Carlos Martín Español , Susan L Ford , Herta Crauwels , David A Margolis , Christine L Talarico , Kimberly Y Smith , Veerle van Eygen , Rodica Van Solingen-Ristea , Simon Vanveggel , William R Spreen

Réseau de co-auteurs

Hans Jaeger 1 collaboration

Edgar T Overton 1 collaboration

Gary Richmond 1 collaboration

Giuliano Rizzardini 1 collaboration

Jaime Federico Andrade-Villanueva 1 collaboration

Rosie Mngqibisa 1 collaboration

Antonio Ocampo Hermida 1 collaboration

Anders Thalme 1 collaboration

Elena Belonosova 1 collaboration

Faïza Ajana 1 collaboration

Paul D Benn 1 collaboration

Yuanyuan Wang 1 collaboration

Krischan J Hudson 1 collaboration

Carlos Martín Español 1 collaboration

Susan L Ford 1 collaboration

Herta Crauwels 1 collaboration

David A Margolis 1 collaboration

Christine L Talarico 1 collaboration

Kimberly Y Smith 1 collaboration

Veerle van Eygen 1 collaboration

Rodica Van Solingen-Ristea 1 collaboration

Simon Vanveggel 1 collaboration

William R Spreen 1 collaboration